ArticleCancer medicine2025
The Invisible Costs of Cancer Treatment: Quantifying Non-Medical Economic Consequences for Cancer Survivors Undergoing Systemic and Radiation Therapies.
Article in Cancer medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
backgroundThe non-medical economic consequences of cancer on individuals and families in low- and middle-income countries, including Bangladesh, remain poorly quantified. This study measures the non-medical economic consequences of cancer survivors and their families, including sacrifices in essential family consumption, social participation and family members' schooling.
methodsWe conducted a cross-sectional survey between January and May 2022, involving 607 adult patients receiving cancer treatment at two tertiary specialised cancer hospitals in Bangladesh. Participants reported any occurrence of non-medical economic consequences: reduction in essential goods (REG) consumption, avoidance of social events (ASE) and cessation of schooling (CS) of family members. We used a multivariable logistic regression model to assess the associations between each non-medical economic consequence and clinical and socioeconomic factors. Additionally, we fitted a Poisson regression to model the count of non-medical economic consequence events as a function of disease stage and relevant covariates.
resultsOverall, 39% of patients reported REG, 36% ASE, and 38% CS. After adjusting for co-variates, advanced cancer (stage IV) was a significant predictor of non-medical economic consequence (REG: OR = 5.58, 95% CI 0.99-31.44, p = 0.051; ASE: 11.35, 1.81-71.07, p = 0.009; SS: 101.56, 2.47-4173.90, p = 0.015) compared with early cancer (stage I). Compared with the highest-income families, patients from low- and lower-middle-income families had significantly higher odds of experiencing all outcomes (REG: OR = 7.57, 3.01-19.06, p < 0.001 and 7.23, 1.81-28.89, p = 0.005; ASE: 10.21, 3.81-27.36, p < 0.001 and 17.99, 4.26-75.96, p < 0.001; CS: 11.37, 3.23-40.00, p < 0.001 and 12.58, 1.90-83.19, p = 0.009). Employed patients were also at markedly higher risk, with substantially increased odds of REG (18.27 times), ASE (41.01 times) and CS (72.34 times) compared with non-employed patients (all p < 0.01).
conclusionCancer treatment in Bangladesh imposes substantial and inequitable non-medical economic consequences, disproportionately affecting patients with advanced-stage cancer, lower-income families and those in active employment. Policymakers may prioritise strengthening early cancer detection programs, expanding targeted financial protection schemes and introducing workplace and educational support mechanisms to safeguard family welfare and promote more equitable outcomes during cancer treatment.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.